Vivoryon Therapeutics N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
03 mei 2016 - 08:03
Statutaire naam
Vivoryon Therapeutics N.V.
Titel
Probiodrug to Attend and Present at European Conferences in May 2016
Bericht
Probiodrug to Attend and Present at European Conferences in May 2016
HALLE/SAALE, Germany, 3 May 2016 - Probiodrug AG ("Probiodrug", Euronext: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease, announces that the company is scheduled to attend the following conferences:
(1) Bio€quity Europe 2016
10 - 11 May 2016, Scandic Hotel, Copenhagen, Denmark
Dr Hendrik Liebers, CFO, to present on Tuesday, 10 May at 11:40 am CET in Ball Room 1
Gerelateerde downloads
Datum laatste update: 23 februari 2026